Pilgrim’s Pride Corporation (NASDAQ:PPC) Receives $44.33 Average PT from Analysts
Pilgrim’s Pride Corporation (NASDAQ:PPC – Get Free Report) has been given an average rating of “Hold” by the six brokerages that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. […]
City Holding Company (NASDAQ:CHCO) Receives $134.50 Average PT from Analysts
City Holding Company (NASDAQ:CHCO – Get Free Report) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price objective among […]
Heritage Commerce Corp (NASDAQ:HTBK) Receives $12.25 Average PT from Analysts
Shares of Heritage Commerce Corp (NASDAQ:HTBK – Get Free Report) have earned a consensus rating of “Hold” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month […]
Expand Energy Corporation (NASDAQ:EXE) Receives $130.29 Average PT from Analysts
Shares of Expand Energy Corporation (NASDAQ:EXE – Get Free Report) have been given an average recommendation of “Buy” by the twenty research firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have assigned a strong buy rating […]
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $89.36 Average PT from Analysts
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and […]
Altimmune, Inc. (NASDAQ:ALT) Receives $17.17 Average PT from Analysts
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and seven have given a buy recommendation to the […]
last updated on 27 Feb 09:11